Overview
Understanding Medicare coverage and payment policy is critical to the successful launch of any new life sciences technology. Foley Hoag’s Medicare Coverage & Payment Practice provides regulatory and legislative advice to a broad array of leading life sciences companies, including:
- global pharmaceutical and biotechnology firms,
- trade associations,
- venture capital and investment funds,
- patient associations and advocacy groups, and
- early-stage companies.
In close collaboration with our clients, we work with senior agency officials, Members of Congress, congressional staff, patient advocates, and healthcare experts to shape agency interpretations, clarify regulatory guidance, and address novel payment issues. Our attorneys and health policy specialists have served as Democratic and Republican Congressional staff and in senior decision-making roles at the Centers for Medicare & Medicaid Services (CMS) and at local Medicare contractors.
Government spending accounts for nearly one-half of the nation’s health expenditures, and Medicare policy decisions have widespread impact on private sector medical coverage and payment. Medicare and other payers are in the middle of a transformation toward evidence-based medicine that rewards value and improved health outcomes. In this new environment, it is critical for companies to develop clinical evidence to support timely, widespread coverage and reimbursement for new technologies. Foley Hoag has deep expertise in working with public and private payers on innovative products and therapies. Our strategy combines convincing legal arguments with a rich understanding of the clinical evidence necessary for widespread adoption and utilization of new products. (continues...)
Download the Foley Hoag Medicare Datasheet (.pdf)